Skip to main content

Table 3 Levels of GFD Compliance in Pediatric Populations.

From: Celiac Disease and Pediatric Type 1 Diabetes: Diagnostic and Treatment Dilemmas

Author

Country

Age

Length of Follow-up

Mode of Follow-up

GFD Compliance (%)

Westman et al. 1999 [67]

Australia

20 CD + DM

6.9–17.4

N/A

7 day food record

30 (strict)

      

30 (trace gluten diet)

      

40 (non-compliant)

Mariani et al. 1998 [68]

Italy

47 CD

N/A

Diary

53.2 (compliant)

     

EMA*

46.8 (non-compliant)

Greco et al. 1997 [69]

Italy

306 CD

12

Unclear

Diary

73 (strict)

     

GI consultant

15 (occasional gluten)

     

Repeat Biopsy

12 (frequent transgressions/full gluten-containing diet)

van Koppen et al. 2009 [70]

Netherlands

32 CD

12–14

10 years

Interview

81 (compliant)

      

19 (non-compliant)

Saadah et al. 2004 [71]

Australia

21 CD + DM

7.5

1 year

Structured telephone questionnaire

25.0 (Excellent)

      

60.0 (Good)

      

5.0 (Fair)

      

10 (Poor)

Wagner et al. 2008 [72]

Austria

283 CD

10–20

N/A

Questionnaire

80.8 (strict)

      

14.9 (2-3 transgressions/month)

      

4.3 (more frequent transgressions)

Hopman et al. 2006 [73]

Netherlands

132 CD

N/A

Questionnaire

75 (strict)

      

23 (occasional consumption)

      

2 (non-compliant)

Jadresin et al. 2008 [74]

Croatia

71 CD

12

 

Questionnaire

53 (strict)

      

26.4 (small amounts of gluten)

      

20.6 (non-compliant)

Fabiani et al. 1996 [61]

Italy

28 CD

11–14

months

Questionnaire

52.2 (strict)

     

EMA

47.8 (occasional transgression)

Rami et al. 2005 [38]

Austria

74 CD + DM

years

EMA

44.6 (compliant)

      

55.4 (non-compliant)

Anson et al. 1990 [75]

Israel

43 CD

18

Assessment of symptoms, biopsy and antireticulin antibodies

70 (compliant)

      

28 (non-compliant)

      

2 (unclassified)

  1. *EMA refers to antiendomysial antibody.